The combination therapy failed to beat out the company’s other cancer therapy, Opdivo, in patients living with melanomas.

IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...

RALEIGH – This week in the North Carolina House of Representatives, Rep. Rodney D. Pierce (District 27) joined three bills with particular relevance for local communities as a primary sponsor.

Margaret Carpenter, based in New Paltz, New York, has been indicted for prescribing abortion pills to a person in Louisiana — ...

After re-staging patients, ideally with PSMA-PET, and performing a biopsy to confirm the recurrence and stratify them into risk categories, it is time to discuss local salvage treatment. Options ...

Santa Barbara, CA – The Cancer Foundation of Santa Barbara is proud to announce that it has awarded a $25,000 grant to Hospice of Santa Barbara to support their Patient Care Services (PCS) program, ...

Bristol Myers Squibb said it is disappointed with the outcome of a study that examined whether one of its drugs could be used to treat a certain type of skin cancer. The drug, Opdualag, didn't meet ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...

Dr. Tyler Perrin-Bellelo said that the initial meeting with a patient for the first time is the most important to “build a ...

San Luis Obispo County residents responded to a survey sent by The Tribune about difficulties accessing primary care here in ...

Talazoparib plus enzalutamide boosts overall survival in metastatic castration-resistant prostate cancer, with HRR-deficient ...